Zimbabwe has declined a substantial US health deal valued at $367m (272 million pounds) over five years due to the United States' request for sensitive information.
This rejection became public following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson later explained that the US was seeking biological samples for research and commercial purposes but refused to share the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged continued dialogue to reach a deal agreeable to both sides so the nation's vital HIV programme can be sustained.
Wider Background
This rejection comes after a similar case in Kenya, where a high court suspended a related deal with the US following concerns were raised about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had managed assistance for the American government, but Trump stated its spending was "wasteful" and his government was seeking direct bilateral deals to enhance openness and responsibility.
As per reports, 16 African countries have so far agreed to similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
This assistance for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation could have provided extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via American-funded initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," his statement read.
"Put simply, our country would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our people if a future disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral deals were undermining systems previously established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to deal with potential pandemics.
"This system is intended to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the capability to develop them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be structured in a way that respects the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body stated it understood the official position, but recommended that talks should continue since a large portion of the country's HIV programmes were funded by external financing.
"If specific concerns exist, including those relating to information security or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it commented.
This impasse underscores the complex tensions between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.